Protalix BioTherapeutics (PLX)
Add to Watchlists Create an AlertProtalix BioTherapeutics Liabilities:
82.08M for Dec. 31, 2012Protalix BioTherapeutics Historical Liabilities Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 82.08M |
| Sept. 30, 2012 | 72.61M |
| June 30, 2012 | 76.44M |
| March 31, 2012 | 74.92M |
| Dec. 31, 2011 | 77.88M |
| Sept. 30, 2011 | 78.18M |
| June 30, 2011 | 80.59M |
| March 31, 2011 | 76.22M |
| Dec. 31, 2010 | 76.05M |
| Sept. 30, 2010 | 78.69M |
| June 30, 2010 | 75.78M |
| March 31, 2010 | 80.23M |
| Dec. 31, 2009 | 82.79M |
| Sept. 30, 2009 | 8.043M |
| June 30, 2009 | 7.27M |
| March 31, 2009 | 6.61M |
| Dec. 31, 2008 | 6.464M |
| Sept. 30, 2008 | 5.393M |
| June 30, 2008 | 5.307M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Total Liabilities
Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.
Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.
Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.
Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More
PLX Liabilities Benchmarks
| Companies | |
|---|---|
| Pfizer | |
| Peregrine Pharmaceuticals | 19.76M |
| Shire | 3.804B |
PLX Liabilities Rankings
| Overall |
74th percentile 2006 of 8005 |
| Sector |
39th percentile 412 of 686 in Healthcare |
| Industry |
31st percentile 171 of 248 in Biotechnology |
PLX Liabilities Range, Past 5 Years
| Minimum | 5.307M | Jun 2008 |
| Maximum | 82.79M | Dec 2009 |
| Average | 55.34M |
